Leslie R. Schover on Male Issues After Cancer Treatment

Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.

During my "watch and wait" time for prostate cancer, I spend this time wisely on things like attending writing webinars.

“Everything happens for a reason,” is among some of the unhelpful things you can say to someone with cancer.